Immunology/Inflammation

Immunology/Inflammation(免疫及炎症)

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

研究方向

Immunology/Inflammation 相关产品(4245)

  • GC73469 structure
    GC73469Cereblon inhibitor 2
    CAS: 2639380-62-2
    纯度: >98.00%

    Cereblon inhibitor 2(化合物8)是一种Cereblon抑制剂,在实体肿瘤研究中非常有用,尤其是乳腺癌。

  • GC73476 structure
    GC73476MYC-RIBOTAC
    纯度: >98.00%

    MYC-RIBOTAC是一个靶向MYC内部核糖体进入位点(IRES)的核糖核酸酶嵌合体(RIBOTAC)。

  • GC73491 structure
    GC73491RapaBlock
    CAS: 2474076-02-1
    纯度: >98.00%

    RapaBlock是一种强效、非免疫抑制和脑不可渗透的FKBP12配体。

  • GC73494 structure
    GC73494MSU-42011
    CAS: 2456434-36-7
    纯度: >98.00%

    MSU-42011是一种口服活性类视黄醇X受体(RXR)激动剂。

  • GC73496 structure
    GC73496ODN INH 18 sodium
    纯度: >96.00%

    ODN INH 18 sodium是一种线性24-mer B类INH-ODN,其中5'INH-ODN4084-F序列后面是12个核苷酸的随机片段,缺乏形成重要二级结构的能力。

  • GC73501 structure
    GC73501Wu-5
    CAS: 2630378-05-9
    纯度: >98.00%

    Wu-5是一种USP10抑制剂,可以抑制FLT3和AMPK通路,诱导FLT3-ITD降解并诱导细胞凋亡。

  • GC73541 structure
    GC73541PRMT5-IN-31
    纯度: >99.00%

    PRMT5-IN-31(化合物3m)是一种选择性PRMT5抑制剂(IC50: 0.31 μM)。

  • GC73543 structure
    GC73543FC-116
    CAS: 2417298-29-2
    纯度: >98.00%

    FC-116是一种有效抑制小鼠肿瘤生长的微管蛋白抑制剂。

  • GC73552 structure
    GC73552TIM-3-IN-2
    CAS: 1113126-49-0
    纯度: >99.00%

    TIM-3-IN-2(化合物A-41)是一种Tim3抑制剂(KD:0.61μM)。

  • GC73555 structure
    GC73555PI3Kδ-IN-16
    CAS: 2766437-35-6
    纯度: >99.00%

    PI3Kδ-IN-16是PI3Kδ的强效选择性抑制剂。

  • GC73561 structure
    GC73561YS-363
    CAS: 2470908-90-6
    纯度: >99.00%

    YS-363是一种强效、选择性和口服活性的EGFR抑制剂,野生型和L858R突变型EGFR的IC50分别为0.96 nM和0.67 nM。

  • GC73567 structure
    GC73567Os30
    CAS: 2998928-68-8
    纯度: >98.00%

    Os30是一种强效的第四代EGFR抑制剂,是一种有效的EGFRC797S-TK抑制剂,对EGFRDel19/T790M/C797S TK和EGFRL858R/T790M/C797S TK的IC50值分别为18 nM和113 nM。

  • GC73569 structure
    GC73569MY-1076
    CAS: 3008262-76-5
    纯度: >99.00%

    MY-1076是YAP的抑制剂。

  • GC73571 structure
    GC73571Tubulin polymerization-IN-56
    CAS: 2966790-98-5
    纯度: >99.00%

    Tubulin polymerization-IN-56吲唑衍生物是一种强效的微管蛋白聚合抑制剂,通过与秋水仙素位点相互作用,导致细胞周期阻滞和细胞凋亡。

  • GC73572 structure
    GC73572PP5-IN-1
    CAS: 1022417-69-1
    纯度: >99.00%

    PP5-IN-1(化合物P053)是一种丝氨酸/苏氨酸蛋白磷酸酶-5 (PP5)的竞争性抑制剂,结合其催化结构域并导致肾癌细胞凋亡。

  • GC73576 structure
    GC73576Enpp-1-IN-19
    CAS: 2738583-25-8
    纯度: >99.00%

    Enpp-1-IN-19(化合物29f)是一种口服活性的ENPP1抑制剂,可抑制ENPP1对cGAMP的水解(IC50=68 nM)。

  • GC73579 structure
    GC73579DDO-2728
    CAS: 3029515-97-4
    纯度: >98.00%

    DDO-2728(化合物19)是一种选择性AlkB同源物5(ALKBH5)抑制剂,IC50为2.97μM。

  • GC73594 structure
    GC73594KH16
    纯度: >98.00%

    KH16是一种有效的低纳摩尔HDAC抑制剂。

  • GC73599 structure
    GC73599TH9619
    CAS: 2379556-22-4
    纯度: >99.00%

    TH9619是MTHFD1和MTHFD2中去磷酸根酶和环磷酸根酶活性的有效抑制剂,IC50值为47nM,并选择性杀死癌症细胞。

  • GC73601 structure
    GC73601UCM-1336
    CAS: 1621535-90-7
    纯度: >99.00%

    UCM-1336是一种有效的ICMT抑制剂,IC50为2μM。

  • GC73627 structure
    GC73627HDAC/JAK/BRD4-IN-1
    CAS: 2755325-84-7
    纯度: >95.00%

    HDAC/JAK/BRD4-IN-1(化合物25ap)是一种强效的HDAC/JAK/BRD4三重抑制剂。

  • GC73629 structure
    GC73629FB49
    纯度: >99.00%

    FB49是一种高选择性的bcl -2相关的无氧基因3 (BAG3)抑制剂,Ki为45 μM。

  • GC73630 structure
    GC73630ZZM-1220
    纯度: >98.00%

    ZZM-1220是一种组蛋白赖氨酸金属转移酶G9a/GLP共价抑制剂,IC50分别为458 nM和924 nM。

  • GC73631 structure
    GC73631FPR1 antagonist 1
    纯度: >95.00%

    FPR1 antagonist 1(化合物24a)是甲酰肽受体1(FPR1)拮抗剂,IC50为25nM。